TGFB1 and glioblastoma: We noted complete rescue of decreased cell viability and TGF-β activity from simvastatin with exogenous mevalonolactone at 100μM or geranylgeranyl-pyrophosphate (GGPP) at 10μM concentration in GBM (Figure 4A) and other cancer cells (Figure 4B).